Month: December 2022
-
2022 Year in Review
Feinberg experienced a year of outstanding growth, scientific achievement, and collaboration in 2022, from honors and awards to unprecedented research discoveries.
-
Northwestern Investigators Develop New Therapy for Autism Subtype
A team of Northwestern investigators led by Peter Penzes, PhD, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder.
-
A Day in the Life: Medical Student Kai Brady
Meet Kai Brady, a second-year MD student at Feinberg School of Medicine, and get a look at a typical day during this phase of her medical school career.
-
2022 IPHAM Forum Celebrates a Long History of Public Health at Northwestern
The Institute for Public Health and Medicine recently hosted its annual Population Health Forum, a celebration of the ten-year anniversary of the institute that brought together hundreds of public health researchers, trainees, and community partners.
-
OB-GYN Research Lacks Racial, Ethnic Inclusivity
Non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, according to a new Northwestern Medicine study.
-
Study Uncovers Potential Therapeutic Approach for Advanced Prostate Cancer
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective therapeutic strategy.
-
Top 3 Breakthroughs Podcasts of 2022
The Breakthroughs podcast released more than 20 episodes in 2022 on topics ranging from the role of dopamine in habit formation to music-based medical interventions.
-
Personalized T-cell Therapy Improves Immune Response Against Cancer
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
-
Watterson Elected to National Academy of Inventors
Daniel Martin Watterson, PhD, the John G. Searle Professor of Molecular Biology and Biochemistry, has been named a 2022 fellow of the National Academy of Inventors.
-
Study Identifies New Therapeutic Target for Tumor Treatment
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.
